InvestorBrandNetwork (IBN) logo

InvestorBrandNetwork (IBN)

The latest articles, editorials and news releases from InvestorBrandNetwork (IBN), a growing Investor Brand Platform.

RSS Feed for InvestorBrandNetwork (IBN)

BioMedNewsBreaks — Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) Builds Foundation for Biomarker-Driven Cancer Therapy

August 14, 2026 — Disseminated on behalf of Onco-Innovations Limited (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) and may include paid advertising. Onco-Innovations (CBOE CA: ONCO) (OTCQB: ONNVF) (Frankfurt: W1H) is advancing its precision oncology strategy through ONC010, a nanoparticle-encapsulated PNKP inhibitor being developed for biomarker-selected cancers.

InvestorNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Builds Commercial Case for GelrinC in Multi-Billion Knee Cartilage Repair Market

August 14, 2026 — Regentis Biomaterials (NYSE American: RGNT) was featured in a recent article highlighting the potential of its GelrinC cell-free hydrogel implant to address longstanding challenges in focal knee injuries through an off-the-shelf treatment designed to simplify surgical workflows, support faster recovery and promote durable tissue regeneration. The company recently received European regulatory approval for a next-generation, solvent-free manufacturing process that increases production yield by approximately 400%, supporting greater scalability and lower production costs.

Earth Science Tech Inc. (ETST) Seeks to Implement a Unified Strategy to Unlock True Market Value and Support Shareholders

August 14, 2026 — Earth Science Tech seeks to implement a unified strategy aimed at maximizing shareholder value, resolving structural hurdles, and elevating corporate governance The company will hold a virtual annual meeting on August 31, 2026, during which shareholders will vote on key initiatives that will position ETST for an uplisting to a higher-tier exchange, eliminate the structural barriers that hinder the infusion of institutional capital, and prevent stock dilution These initiatives are informed by extensive dialogue between shareholders and management leading to a consensus that the company’s current market valuation simply does not accurately reflect its financial success or future potential The recent annual financial results posted by Earth Science Tech (OTC: ETST) reflect significant success and growth, which the diversified holding company attributes to an overarching focus on optimizing internal operations. The company, for instance, logged consecutive year-over-year increases in revenue and gross profit in the two years to March 31, 2026 (https://nnw.

MissionIRNewsBreaks – Wrap Technologies, Inc. (NASDAQ: WRAP) Selected to Support Florida Teacher Safety Training Program

August 14, 2026 — Wrap Technologies (NASDAQ: WRAP) has been selected by WOFT Charities (“WOFT”) to provide training support for the WOFT Teacher Safety Training Program, which received a $475,000 appropriation in Florida’s fiscal year 2026-27 state budget. WRAP will support training focused on situational awareness, threat recognition, early intervention, de-escalation and avoiding physical confrontation when possible.

Fund Manager Forecasts Gold’s Return to $5,000 Price Level

August 14, 2026 — Gold could eventually climb back to $5,000 an ounce, although investors may have to wait several years for the metal to reach that level. This is according to David Miller, CIO and co-founder of Catalyst Funds and portfolio manager of the Strategy Shares Gold Enhanced Yield ETF.

AI Model Helps China Generate Renewables Reliably

August 14, 2026 — China is using artificial intelligence to run real-time analysis of pertinent data points and increase its renewable energy infrastructure’s reliability. In June, an AI model was rolled out at the massive Yalong River integrated renewable base in Sichuan Province to help the mega-scale power generation hub address issues such as output instability and intermittency.

Robinhood Starts Enabling Crypto Trading in the UK

August 14, 2026 — Robinhood has expanded its presence in the UK’s digital-asset market with the launch of crypto trading for eligible customers, giving users access to over 50 tokens through its investment app. Robinhood’s debut of crypto trading services in its UK operations is likely to be welcomed by the wider crypto industry, including leading firms like Marathon Digital Holdings Inc.

Experts Say People, Not AI, Are the Biggest Threat

August 14, 2026 — Artificial intelligence is becoming more powerful every day, raising concerns about whether machines could eventually become a major threat to people and businesses. However, cybersecurity experts say the biggest danger is still not AI itself.

Little-Known Immune Cells Bolster Anticancer Fight, Study Finds

August 14, 2026 — Researchers from the University of Manchester in the UK have found that a small group of immune cells that aren’t given much attention by scientists is actually crucial in mobilizing the immune system to attack and sustain its fight against cancer. It would be interesting to see what would happen if enterprises like Calidi Biotherapeutics Inc.

Sales of Chinese EVs Surge Across Europe

August 14, 2026 — Data from Schmidt Automotive Research has revealed that sales of Chinese electric vehicles surged across Europe in the first five months of 2026. European buyers purchased a record number of battery electric vehicles (BEVs) from Chinese brands, causing their European market share to jump by 5% compared to the first five months of 2025.

Apple Considers Using Chips from Chinese Manufacturer CXMF as Shortages Bite

August 14, 2026 — According to media reports, Apple has been weighing a switch to storage and memory chips produced by Chinese firm CXMF in a bid to offset supply shortages triggered by the AI boom. The American tech company is initially looking to use those chips in the products it sells on the Chinese market.

Regentis Biomaterials Ltd. (NYSE American: RGNT) Moves GelrinC Along Parallel US Clinical and European Commercial Tracks

August 14, 2026 — Regentis has passed 50% enrollment in the pivotal Phase III SAGE study of GelrinC, with recruitment completion targeted for the third quarter of 2026 and a PMA process expected to begin by the end of 2027. FDA approved a single-arm protocol using a historical microfracture control data package the company owns, and Regentis reports that the first 40 patients closely match that control group.